Bacteriophages, also known as phages, are viruses that infect and replicate only in bacterial cells. They are ubiquitous in the environment and are recognized as the most abundant biological agent on earth. They are extremely diverse in size, morphology, and genomic organization. However, all consist of a nucleic acid genome encased in a shell of phage-encoded capsid proteins, which protect the genetic material and mediate its delivery into the next host cell. Electron microscopy has allowed the detailed visualization of hundreds of phage types, some of which appear to have "heads," "legs," and "tails." Despite this appearance, phages are non-motile and depend upon a Brownian motion to reach their targets.
Like all viruses, bacteriophages are very species-specific with regard to their hosts and usually only infect a single, bacterial species, or even specific strains within a species. Once a bacteriophage attaches to a susceptible host, it pursues one of two replication strategies: lytic or lysogenic. During a lytic replication cycle, a phage attaches to a susceptible host bacterium, introduces its genome into the host cell cytoplasm, and utilizes the ribosomes of the host to manufacture its proteins. The host cell resources are rapidly converted to viral genomes and capsid proteins, which assemble into multiple copies of the original phage. As the host cell dies, it is either actively or passively lysed, releasing the new bacteriophage to infect another host cell. In the lysogenic replication cycle, the phage also attaches to a susceptible host bacterium and introduces its genome into the host cell cytoplasm. However, the phage genome is instead integrated into the bacterial cell chromosome or maintained as an episomal element where, in both cases, it is replicated and passed on to daughter bacterial cells without killing them. Integrated phage genomes are termed prophages, and the bacteria containing them are termed lysogens. Prophages can convert back to a lytic replication cycle and kill their host, most often in response to changing environmental conditions.
Although bacteriophages cannot infect and replicate in human cells, they are an important part of the human microbiome and a critical mediator of genetic exchange between pathogenic and non-pathogenic bacteria. The transfer of genes from one bacterial strain to another by a bacteriophage is called transduction and can occur in a generalized or specific manner. In "generalized" transduction, random pieces of bacterial genomic DNA are packaged inside of phage capsids in place of phage genomic DNA as the host cell is disintegrating from lytic replication. Should the phage carrying this bacterial DNA inject it into a healthy host cell, it may integrate into the chromosome of that bacterium, altering its genome and that of its daughter cells. In "specialized" transduction, it is thought that lysogenic phages, which have been amplified in a population of bacteria, excise some bacterial DNA with their genome when initiating a lytic replication cycle. Because the lysogens share the same integration site, all progeny phages transduce the same bacterial gene to their new hosts.
In addition to genetic exchange, bacteriophages can alter microbial populations because they prey on specific species of bacteria while leaving others unharmed. For more than 100 years, research has attempted to use this property as a means to treat pathogenic bacterial infections in people and animals. While wild phages probably do have transient effects on wild bacterial populations, many obstacles to the clinical use of lytic bacteriophages as an antimicrobial therapy (phage therapy) in humans exist. For one, wild bacterial strains are very diverse, and many are resistant to one or multiple phages. Many resistance mechanisms are known, with one famous example, the CRISPR-Cas9 system now engineered as a tool for genetic manipulation in the lab, originated as a bacterial defense mechanism against bacteriophage infection. In addition, phages are much more immunogenic than antimicrobial drugs and are rapidly cleared from the blood by the reticular endothelial system. Their large size relative to antimicrobial drugs also will likely limit their use to topical applications if effective phage cocktails are found. Some investigators have suggested that using phage enzymes which can penetrate bacterial cell walls may be a more straightforword strategy. To date, there have been no randomized, controlled, double-blind trials showing efficacy of either strategy in humans.
Phages are clinically significant for several reasons. First, many highly pathogenic bacterial toxins are encoded by bacteriophage genomes, such that the host bacterium is only pathogenic when lysogenized by the toxin-encoding phage. Examples are cholera toxin in Vibrio cholerae, diphtheria toxin in Corynebacterium diphtheriae, botulinum neurotoxin in Clostridium botulinum, the binary toxin of Clostridium difficile, and Shiga toxin of Shigella species. Without their phage-encoded toxins, these bacterial species are either much less pathogenic or not pathogenic at all. Why phages encode these toxins is not known. While cholera toxin arguably helps both the phage and its host reach their next victim by inducing copious, watery diarrhea, the paralysis resulting from botulinum toxin would seem to have the opposite effect.
Second, bacteriophages are vectors for horizontal gene transfer, which may include antimicrobial resistance genes. They also have been engineered to introduce genes into specific strains for clinical effect, although this use is currently in the testing stage.
A third clinically relevant aspect of bacteriophages is that their detection can be used as a biomarker for the presence of their host in a complex environmental sample. This most commonly is used as a surrogate for fecal contamination of water sources. If the phage is present, the host most likely is as well. Alternatively, phages have been engineered to produce a detectable molecule, such as luciferase, when they infect their host as a means to detect bacteria in a mixed environmental sample.
While mostly supplanted by newer technologies, bacteriophages also are clinically relevant for their ability to distinguish strains of the same bacterial species. Most species of bacteria studied have multiple bacteriophage pathogens, just as humans as a species are susceptible to multiple viruses. Different strains within a species are resistant to some phages and not others. By infecting each strain systematically with a standardized panel of phages for that species, each strain can be identified by the pattern of susceptibility and resistance to each phage type. Phage typing of Staphylococcus aureus, for example, utilized a standardized panel of bacteriophages shared internationally to differentiate strains of S. aureus. Before the development of molecular methods for this purpose, such as multilocus sequence typing and pulsed-field gel electrophoresis, phage typing was the criterion standard for tracking strains for epidemiological purposes.
Finally, bacteriophages were the first type of virus to be discovered and were a part of many of the fundamental discoveries of molecular biology. For example, the proof that DNA was the molecule that transmitted genetic information, the basic mechanisms of gene regulation, and the genetic code to name but a few, were all discovered using bacteriophages.
Antibiotic Resistance and Infection Control
Bacteriophage are drivers of bacterial evolution in the human microbiome (Level II evidence). Prophage can be induced to switch to the lytic replication cycle by host cell stress, including antimicrobial drugs. Therefore, antibiotic treatments, especially those targeting gut microbial flora, can be expected to alter the viral (phage) microbiome as well. Bacteriophage are not as easily inactivated as vegetative bacterial cells, but they are vulnerable to UV inactivation, autoclaving, and standard hospital disinfection procedures.
Bacterial Toxin Mediated Disease
It is important for all team members caring for a patient with a phage-borne toxin-mediated disease, such as cholera or shigella, that disinfection procedures should be chosen for their ability to inactivate viruses as well as for bacteria. Even though the bacteriophage do not infect human cells directly, they can mediate virulence gene transfer from pathogenic to non-pathogenic bacterial strains.
|||Simmonds P,Aiewsakun P, Virus classification - where do you draw the line? Archives of virology. 2018 Aug [PubMed PMID: 30039318]|
|||Doore SM,Fane BA, The microviridae: Diversity, assembly, and experimental evolution. Virology. 2016 Apr [PubMed PMID: 26874016]|
|||Ptashne M, Lambda's switch: lessons from a module swap. Current biology : CB. 2006 Jun 20 [PubMed PMID: 16782001]|
|||[PubMed PMID: 30763535]|
|||Pham TD,Nguyen TH,Iwashita H,Takemura T,Morita K,Yamashiro T, Comparative analyses of CTX prophage region of Vibrio cholerae seventh pandemic wave 1 strains isolated in Asia. Microbiology and immunology. 2018 Oct; [PubMed PMID: 30211956]|
|||Holmes RK, Biology and molecular epidemiology of diphtheria toxin and the tox gene. The Journal of infectious diseases. 2000 Feb; [PubMed PMID: 10657208]|
|||[PubMed PMID: 29050666]|
|||[PubMed PMID: 30233520]|
|||[PubMed PMID: 26931607]|
|||[PubMed PMID: 23050221]|
|||[PubMed PMID: 22532090]|